Over the course of 2013, India's healthcare sector took several steps to strengthen drug and clinical trial regulations, re-established the elected Medical Council of India, and made progress in the Health Ministry's work to develop alternative and cheaper technologies like an indigenous... Read More
Japan is the second largest medical device market in the world. Getting through the registration process and selling your product on the market is not an easy task. This webcast will focus on key steps including PMDA consultation sessions, how to maximize... Read More
Indonesia, a country of more than 6,000 inhabited islands, has a population of over 250 million people -- the fourth most populous country in the world. Indonesia's GDP grew slightly less than 6% in 2013, and is forecast to grow between 5-6%... Read More
The Philippines, a Southeast Asian country made up of more than 7,000 islands, has a population of over 100 million people -- making it the 12th most populous country. 2013 Philippine GDP growth was among the fastest in Asia, at almost 7%.... Read More
印度立法委员再次延缓关于一项已提交议案的讨论，此议案将在印度史上首次对于所有在印度境内生产或销售的医疗产品进行全面性的法规约束。2013药品和化妆品法案（修订案）要求为医疗器械建立单独的类别，并且创建医疗器械专家咨询委员会，为执法者提供咨询建议。 Read More
Indian legislators again delayed the discussion of a proposed bill that would, for the first time in the country's history, require comprehensive regulation of all medical devices manufactured in or sold in India. The Drugs and Cosmetics (Amendment) Bill 2013 calls for... Read More
China’s pharmaceutical market is booming! The market is growing almost 15% annually and is expected to be about $100 billion dollars in 2017. However, drug regulations are complicated in China. In addition, once your drug is approved, what needs to be done... Read More
Certain high-risk Class III medical devices will be subject to clinical trial pre-approval under a new catalogue proposed by China’s Food and Drug Administration (CFDA). The Catalogue of Class III Medical Devices Subject to Clinical Trial Authorization was released on September 30,... Read More
Japan’s Ministry of Health and Welfare (MOH) is formulating new rules that could further open up the country’s over the counter (OTC) drugs market for online sales. Since the online sales ban was lifted in June 2013, there have been no clear... Read More
China’s Food and Drug Administration (CFDA) announced on August 23 that all applicants for GMP certification for pharmaceutical products must now submit their materials electronically. According to the Chinese language notification, materials must be submitted to the website of the Center for... Read More